+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Arbovirus Testing Market by Test Type, Technology, End User, Application, Sample Type - Global Forecast to 2030- Product Image
Arbovirus Testing Market by Test Type, Technology, End User, Application, Sample Type - Global Forecast to 2030- Product Image
Sale

Arbovirus Testing Market by Test Type, Technology, End User, Application, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887482
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Arbovirus Testing Market grew from USD 1.31 billion in 2024 to USD 1.39 billion in 2025. It is expected to continue growing at a CAGR of 5.87%, reaching USD 1.85 billion by 2030.

Setting the Stage for Next-Generation Arbovirus Diagnostics

Arboviruses pose a growing global health threat, with outbreaks of dengue, Zika and chikungunya demanding rapid diagnostic responses. The evolving interplay of environmental factors, increased travel and urbanization has elevated the urgency for robust testing solutions. Stakeholders must understand how the convergence of scientific breakthroughs and regulatory shifts shapes both diagnostic capabilities and market opportunities.

This executive summary distills critical aspects of the arbovirus testing landscape, offering insights into emerging technology trends, tariff implications and core market segments. Strategic analyses of regional performance and leading company activities provide a clear view of competitive dynamics and investment hotspots. Actionable recommendations are crafted to support industry leaders in navigating an increasingly complex environment.

By synthesizing qualitative and quantitative research, this summary equips decision-makers with the context needed to prioritize innovation, optimize supply chains and respond proactively to policy changes. It establishes a comprehensive foundation for deeper exploration of market drivers and challenges, setting the stage for informed strategy development.

Transformative Forces Driving Arbovirus Testing

Arbovirus testing has undergone transformative evolution driven by both scientific innovation and shifting epidemiological patterns. Climate change and expanded vector habitats have broadened disease prevalence, prompting investment in technologies that deliver faster, more accurate detection. Recent breakthroughs in molecular and serological platforms have enabled a transition from centralized laboratory testing toward decentralized, point-of-care diagnostics.

Concurrently, regulatory authorities have accelerated approval pathways for emergency use, reflecting lessons learned from recent pandemics. This has catalyzed partnerships between diagnostic developers and public health agencies, fostering rapid assay validation and deployment. Digital integration, such as cloud-based data analytics linked to real-time PCR systems, has further enhanced epidemiological surveillance capabilities.

Industry stakeholders are now balancing the need for high-throughput automated workflows with demands for low-cost, field-deployable rapid assays. This dynamic has spurred convergence between established instrumentation providers and emerging biotech firms. As the market shifts, organizations must remain agile, leveraging adaptive study designs and modular platforms to address the diverse requirements of clinical, research and veterinary applications.

Assessing the Impact of 2025 US Tariffs on Arbovirus Testing

In 2025, new United States tariffs on imported diagnostic reagents, instruments and consumables are poised to reshape the cost structure of arbovirus testing. These measures target key components sourced from international suppliers, resulting in increased procurement expenses for laboratories and healthcare providers. The ripple effect is expected to drive contract renegotiations, procurement diversification and potential price adjustments passed down to end users.

Diagnostic manufacturers are responding by expanding domestic production capabilities and forging strategic alliances with local contract manufacturers. This shift toward near-shoring mitigates tariff exposure while enhancing supply chain resilience. At the same time, organizations are evaluating alternative reagent formulations and qualifying additional vendors to reduce dependency on tariff-impacted imports.

Hospitals, diagnostic laboratories and research institutions are adapting purchasing strategies, prioritizing long-term framework agreements to lock in pricing and secure inventory. Although short-term cost pressures may intensify, the transition to localized manufacturing and diversified sourcing is expected to stabilize margins over the medium term. Companies that proactively adjust their supply chain models will gain a competitive edge by offering more predictable pricing and assured access to critical testing components.

Decoding Core Segments Shaping Arbovirus Testing

A nuanced examination of market segments reveals distinct growth trajectories across test types, technologies, end users, applications and sample matrices. Molecular tests continue to dominate revenue share due to their unmatched sensitivity in detecting viral RNA, while rapid diagnostic tests are carving out space in field settings because of their ease of use and swift turnaround. Serological tests remain indispensable for epidemiological surveillance, tracking antibody responses over time.

Technological differentiation is equally pronounced. Sandwich, indirect and competitive ELISA formats provide robust platforms for antibody quantification, whereas competitive and sandwich lateral flow assays deliver portable solutions for point-of-care screening. DNA and protein microarrays offer high-throughput multiplexing capabilities, and conventional, real-time and digital PCR technologies address a spectrum of sensitivity and quantitation needs.

Diagnostic laboratories represent the largest end-user segment, leveraging high-capacity infrastructure for both clinical and research diagnostics. Hospitals maintain a strong presence in acute care settings, while pharmaceutical companies and research institutions drive demand through vaccine development and fundamental investigations. Clinical diagnostics accounts for the primary application, supported by epidemiological surveillance efforts that inform outbreak response. Veterinary testing is emerging as a critical sub-sector amid concerns about zoonotic spillover.

Among sample types, plasma and serum remain the standards for laboratory workflows, while whole blood, saliva and urine are gaining traction for minimally invasive collection, broadening patient access and enhancing surveillance programs.

Mapping Regional Strengths in Arbovirus Testing

The Americas exhibit mature diagnostic ecosystems characterized by established reimbursement frameworks, advanced laboratory infrastructure and extensive public health surveillance networks. These factors support rapid adoption of high-end molecular platforms and foster collaboration between government agencies and private entities.

Europe, Middle East & Africa region presents a multifaceted landscape, driven by harmonization of regulatory standards and growing investment in healthcare modernization. While Western Europe maintains stable demand for automated diagnostics, emerging markets in the Middle East and Africa are prioritizing scalable rapid testing solutions to overcome resource constraints.

Asia-Pacific is marked by dynamic growth in research and clinical diagnostics, underpinned by expanding biomedical R&D funding and domestic manufacturing capacities. This region benefits from large-scale infectious disease monitoring programs, with governments incentivizing adoption of novel platforms. Localized assay development and cost-effective manufacturing have positioned Asia-Pacific as a nexus for innovation and supply chain diversification.

Leading Enterprises Shaping the Competitive Arena

Leading industry participants showcase diverse strategies to capture growth in the arbovirus testing market. Global instrumentation providers are enhancing their portfolios through acquisition of niche assay developers and by integrating digital analytics for remote monitoring. Biotech firms are focusing on platform versatility, investing in multiplex assays that can simultaneously detect multiple arboviruses and other co-circulating pathogens.

Collaborations between diagnostic companies and pharmaceutical manufacturers are accelerating companion diagnostics for vaccine efficacy studies and therapeutic monitoring. Through research partnerships and co-development agreements, organizations are streamlining regulatory pathways and expanding clinical trial networks. Key players are also strengthening their regional footprints by establishing local manufacturing units in high-growth markets, reducing lead times and mitigating trade-related uncertainties.

Innovation pipelines reveal a trend toward next-generation sequencing integration and the use of CRISPR-based detection systems. These cutting-edge technologies promise ultra-rapid turnaround and exceptional specificity, positioning early adopters to redefine performance benchmarks. Overall, companies that leverage collaborative ecosystems and invest in both breadth and depth of assay offerings will emerge as frontrunners in the competitive landscape.

Strategic Recommendations for Arbovirus Testing Leaders

Industry leaders should prioritize modular test platforms that can adapt swiftly to new pathogen emergence while maintaining cost efficiency for high-volume screening. Investing in regional manufacturing hubs will not only alleviate tariff pressures but also reinforce supply chain resilience, ensuring uninterrupted access to critical reagents and consumables.

Developing strategic partnerships with public health agencies and research institutions will accelerate validation and adoption of innovative assays. By co-funding epidemiological studies, companies can generate real-world performance data and strengthen market credibility. Integrating artificial intelligence-driven analytics into molecular workflows will enhance predictive surveillance and optimize resource allocation during outbreaks.

Focusing on minimally invasive sample collection methods, such as saliva and urine testing, can expand diagnostic reach into low-resource and remote settings. Cultivating a diversified portfolio that balances high-throughput laboratory instruments with cost-effective rapid tests will enable organizations to address both acute clinical needs and large-scale surveillance initiatives. Finally, proactive engagement with regulatory bodies to shape favorable approval pathways will accelerate time-to-market and reinforce long-term competitive positioning.

Rigorous Framework Underpinning the Research

This analysis employed a rigorous multi-stage methodology designed to ensure data integrity and comprehensive coverage. Primary research involved in-depth interviews with virology and diagnostic experts, procurement leads at healthcare institutions and senior R&D executives. Secondary research drew upon peer-reviewed journals, regulatory submissions, company financial disclosures and global trade databases.

Data triangulation techniques were applied to reconcile differing information sources and validate key findings. Market segmentation was defined along five critical dimensions, with each category subjected to cross-verification against publicly available epidemiological and sales data. Regional insights were informed by an analysis of healthcare expenditure, surveillance program reports and local manufacturing capabilities.

A structured peer review process was conducted by subject-matter specialists to ensure methodological robustness and to mitigate potential biases. Limitations related to rapidly evolving regulatory environments and emerging technologies were acknowledged, with contingency measures outlined for continuous data updates. The resulting framework offers a transparent, replicable foundation for strategic decision-making in the arbovirus testing domain.

Synthesizing Insights for Arbovirus Testing Success

The insights presented underscore a pivotal moment for the arbovirus testing market, as regulatory, technological and geopolitical factors converge to reshape industry paradigms. Tariff-induced supply chain realignments and the rise of decentralized diagnostics highlight the necessity for agility in both manufacturing and distribution strategies.

Segmentation analysis reveals that sustained growth will hinge on versatile platforms capable of multiplex detection and streamlined workflows that accommodate diverse sample types. Regional distinctions emphasize the importance of tailored value propositions-leveraging advanced molecular solutions in mature markets while deploying rapid, cost-effective assays in emerging economies.

Ultimately, companies that blend innovation with strategic foresight-anticipating policy shifts, forging collaborative research partnerships and optimizing operational resilience-are best positioned to capture the evolving opportunities within arbovirus testing. This synthesis of market dynamics and actionable recommendations provides a strategic roadmap for stakeholders aiming to enhance public health outcomes and drive long-term business success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Molecular Tests
    • Rapid Diagnostic Tests
    • Serological Tests
  • Technology
    • ELISA
      • Competitive ELISA
      • Indirect ELISA
      • Sandwich ELISA
    • Lateral Flow Assays
      • Competitive Assay
      • Sandwich Assay
    • Microarray
      • DNA Microarray
      • Protein Microarray
    • PCR Technology
      • Conventional PCR
      • Digital PCR
      • Real-Time PCR
  • End User
    • Diagnostic Laboratories
    • Hospitals
    • Pharmaceutical Companies
    • Research Institutions
  • Application
    • Clinical Diagnostics
    • Epidemiological Surveillance
    • Research
    • Veterinary Testing
  • Sample Type
    • Plasma
    • Saliva
    • Serum
    • Urine
    • Whole Blood
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • QIAGEN N.V.
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Siemens Healthineers AG
  • PerkinElmer, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Arbovirus Testing Market, by Test Type
8.1. Introduction
8.2. Molecular Tests
8.3. Rapid Diagnostic Tests
8.4. Serological Tests
9. Arbovirus Testing Market, by Technology
9.1. Introduction
9.2. ELISA
9.2.1. Competitive ELISA
9.2.2. Indirect ELISA
9.2.3. Sandwich ELISA
9.3. Lateral Flow Assays
9.3.1. Competitive Assay
9.3.2. Sandwich Assay
9.4. Microarray
9.4.1. DNA Microarray
9.4.2. Protein Microarray
9.5. PCR Technology
9.5.1. Conventional PCR
9.5.2. Digital PCR
9.5.3. Real-Time PCR
10. Arbovirus Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Pharmaceutical Companies
10.5. Research Institutions
11. Arbovirus Testing Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.3. Epidemiological Surveillance
11.4. Research
11.5. Veterinary Testing
12. Arbovirus Testing Market, by Sample Type
12.1. Introduction
12.2. Plasma
12.3. Saliva
12.4. Serum
12.5. Urine
12.6. Whole Blood
13. Americas Arbovirus Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Arbovirus Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Arbovirus Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. bioMérieux SA
16.3.5. QIAGEN N.V.
16.3.6. Hologic, Inc.
16.3.7. Becton, Dickinson and Company
16.3.8. Danaher Corporation
16.3.9. Siemens Healthineers AG
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARBOVIRUS TESTING MARKET MULTI-CURRENCY
FIGURE 2. ARBOVIRUS TESTING MARKET MULTI-LANGUAGE
FIGURE 3. ARBOVIRUS TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARBOVIRUS TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. CANADA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 68. CANADA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 69. CANADA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 70. CANADA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. CANADA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 147. ITALY ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. ITALY ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. ITALY ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 150. ITALY ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 151. ITALY ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 152. ITALY ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. ITALY ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ITALY ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. ITALY ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 157. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 159. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 160. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 161. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 192. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 196. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 197. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 210. QATAR ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. QATAR ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. QATAR ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 213. QATAR ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 214. QATAR ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 215. QATAR ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. QATAR ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. QATAR ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. QATAR ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 250. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 251. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 255. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 256. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 258. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 259. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 260. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 282. POLAND ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. POLAND ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 285. POLAND ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 286. POLAND ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 287. POLAND ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. POLAND ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. POLAND ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. POLAND ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 310. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 311. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. CHINA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 313. CHINA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 314. CHINA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 315. CHINA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. CHINA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. CHINA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. CHINA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 319. INDIA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDIA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. INDIA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 322. INDIA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 323. INDIA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 324. INDIA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. INDIA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. INDIA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. INDIA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 328. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 329. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 331. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 332. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 333. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 334. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 343. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 352. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 353. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TA

Companies Mentioned

The companies profiled in this Arbovirus Testing market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • QIAGEN N.V.
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Siemens Healthineers AG
  • PerkinElmer, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.85 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Arbovirus Testing Market Size, Share & Trends Analysis Report by Type (ELISA-Based Tests, RT-PCR Based Tests), End-use (Diagnostic Laboratories, Hospitals, Research Centers), Region, with Growth Forecasts, 2025-2030 - Product Image

Arbovirus Testing Market Size, Share & Trends Analysis Report by Type (ELISA-Based Tests, RT-PCR Based Tests), End-use (Diagnostic Laboratories, Hospitals, Research Centers), Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Arbovirus Testing - Global Strategic Business Report - Product Image

Arbovirus Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Arbovirus Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Arbovirus Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 100 Pages
  • Global
From
Arbovirus Testing Market 2024-2028 - Product Image

Arbovirus Testing Market 2024-2028

  • Report
  • 144 Pages
  • Global
From
Arthropod-borne Viral Infections Testing Market by Test Type, Technology, End User, Sample Type, Disease Type - Global Forecast to 2030 - Product Image

Arthropod-borne Viral Infections Testing Market by Test Type, Technology, End User, Sample Type, Disease Type - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From

About the Arbovirus Testing Market

The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population. Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.